This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): becaplermin
Description: The active ingredient of Regranex gel, becaplermin, is recombinant human platelet-derived growth factor (PDGF). This growth factor stimulates the migration of cells to the ulcer site, encouraging the patient's body to grow new tissue that heals the open wound.
Partners: Johnson & Johnson
Pink Sheet In Brief: Chiron Regranex
Pink Sheet Regranex MedWatch Cancer
Pink Sheet In Brief: J&J Regranex
Additional information available to subscribers only: